New Key Statistics Module, Z-Score and F-Score
NAS:IRWD Key Ratios
| Market Cap $ M | 1,314.57 |
| Enterprise Value $ M | 1,927.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 3.15 |
| Price/Free Cash Flow | 7.78 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 442.00 |
| EPS (TTM) $ | -6.51 |
| Beneish M-Score | -3.92 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -524.10 |
| EV-to-EBIT | -2.08 |
| EV-to-EBITDA | -2.08 |
| PEG | -- |
| Shares Outstanding M | 158.96 |
| Net Margin (%) | -226.37 |
| Operating Margin % | 38.02 |
| Pre-tax Margin (%) | -214.14 |
| Quick Ratio | 0.84 |
| Current Ratio | 0.84 |
| ROA % (ttm) | -130.02 |
| ROE % (ttm) | -1,456.68 |
| ROIC % (ttm) | 38.76 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.75 |
IRWD Number of Guru Trades
IRWD Volume of Guru Trades
Gurus Latest Trades with NAS:IRWD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IRWD is held by these investors
Total 5
Ironwood Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IRWD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers